Literature DB >> 31955363

Selected cardiovascular risk factors in early stages of chronic kidney disease.

Joanna Jagieła1, Piotr Bartnicki2, Jacek Rysz2.   

Abstract

Cardiovascular diseases, including hypertension, congestive heart failure, myocardial infarction, stroke and atherosclerosis, are common in patients with chronic kidney disease. Aside from the standard biomarkers, measured to determine cardiovascular risk, new ones have emerged: markers of oxidative stress, apoptosis, inflammation, vascular endothelium dysfunction, atherosclerosis, organ calcification and fibrosis. Unfortunately, their utility for routine clinical application remains to be elucidated. A causal relationship between new markers and cardiovascular diseases in patients with chronic kidney disease remains to be established. First of all, there is a lack of large, randomized trials. Moreover, most studies focus on patients with end-stage renal disease as well as on dialysed patients. In such patients, cardiovascular diseases are already present and advanced while early detection of cardiovascular disease risk factor in patients with early-stages of chronic kidney disease would allow more precise prognosis and, as a result, changes in treatment algorithm. In this article, we conduct a comprehensive review of literature for publications relating to cardiovascular risk factors in patients with early-stages of chronic kidney disease. Overall, there are many encouraging advances in detection of cardiovascular risk factors that are making the future more promising for patients suffering from chronic kidney disease.

Entities:  

Keywords:  Apoptosis markers; Cardiovascular risk factors; Chronic kidney disease; Oxidative stress markers

Mesh:

Year:  2020        PMID: 31955363     DOI: 10.1007/s11255-019-02349-1

Source DB:  PubMed          Journal:  Int Urol Nephrol        ISSN: 0301-1623            Impact factor:   2.370


  106 in total

Review 1.  Mechanisms of renal apoptosis in health and disease.

Authors:  Ana Belen Sanz; Beatriz Santamaría; Marta Ruiz-Ortega; Jesus Egido; Alberto Ortiz
Journal:  J Am Soc Nephrol       Date:  2008-07-16       Impact factor: 10.121

Review 2.  Role of oxidative stress in cardiovascular diseases.

Authors:  N S Dhalla; R M Temsah; T Netticadan
Journal:  J Hypertens       Date:  2000-06       Impact factor: 4.844

3.  Reciprocal association of plasma adiponectin and serum C-reactive protein concentration in haemodialysis patients with end-stage kidney disease--a follow-up study.

Authors:  Witold Ignacy; Jerzy Chudek; Marcin Adamczak; Tohru Funahashi; Yuji Matsuzawa; Franciszek Kokot; Andrzej Wiecek
Journal:  Nephron Clin Pract       Date:  2005-05-09

4.  Endothelial dysfunction in chronic renal failure: roles of lipoprotein oxidation and pro-inflammatory cytokines.

Authors:  C H Bolton; L G Downs; J G Victory; J F Dwight; C R Tomson; M I Mackness; J H Pinkney
Journal:  Nephrol Dial Transplant       Date:  2001-06       Impact factor: 5.992

5.  Plasma concentration of asymmetrical dimethylarginine and mortality in patients with end-stage renal disease: a prospective study.

Authors:  C Zoccali; S Bode-Böger; F Mallamaci; F Benedetto; G Tripepi; L Malatino; A Cataliotti; I Bellanuova; I Fermo; J Frölich; R Böger
Journal:  Lancet       Date:  2001 Dec 22-29       Impact factor: 79.321

6.  Cardiovascular disease in patients with chronic kidney disease: a neglected subgroup.

Authors:  Arun Kumar Subbiah; Yogesh K Chhabra; Sandeep Mahajan
Journal:  Heart Asia       Date:  2016-11-07

7.  Hyperhomocysteinemia and the development of chronic kidney disease in a general population: the Hisayama study.

Authors:  Toshiharu Ninomiya; Yutaka Kiyohara; Michiaki Kubo; Yumihiro Tanizaki; Keiichi Tanaka; Ken Okubo; Hidetoshi Nakamura; Jun Hata; Yoshinori Oishi; Isao Kato; Hideki Hirakata; Mitsuo Iida
Journal:  Am J Kidney Dis       Date:  2004-09       Impact factor: 8.860

8.  Soluble adhesion molecules in end-stage renal disease: a predictor of outcome.

Authors:  Mohamed E Suliman; A Rashid Qureshi; Olof Heimbürger; Bengt Lindholm; Peter Stenvinkel
Journal:  Nephrol Dial Transplant       Date:  2006-02-13       Impact factor: 5.992

9.  Chronic kidney disease and cardiovascular disease in the Medicare population.

Authors:  Allan J Collins; Shuling Li; David T Gilbertson; Jiannong Liu; Shu-Cheng Chen; Charles A Herzog
Journal:  Kidney Int Suppl       Date:  2003-11       Impact factor: 10.545

10.  10. Cardiovascular Risk in Chronic Kidney Disease.

Authors:  Mitja Lainščak
Journal:  EJIFCC       Date:  2009-04-20
View more
  1 in total

Review 1.  Inflammation and Cardiovascular Disease Associated With Hemodialysis for End-Stage Renal Disease.

Authors:  Yinghui Wang; Lu Gao
Journal:  Front Pharmacol       Date:  2022-02-10       Impact factor: 5.810

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.